ID   STT3A_HUMAN             Reviewed;         705 AA.
AC   P46977; B4DJ24; E9PNQ1; Q86XU9; Q8TE35; Q8WUB4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 2.
DT   10-MAY-2017, entry version 146.
DE   RecName: Full=Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A;
DE            Short=Oligosaccharyl transferase subunit STT3A;
DE            Short=STT3-A;
DE            EC=2.4.99.18;
DE   AltName: Full=B5;
DE   AltName: Full=Integral membrane protein 1;
DE   AltName: Full=Transmembrane protein TMC;
GN   Name=STT3A; Synonyms=ITM1, TMC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8838310; DOI=10.1006/geno.1996.0051;
RA   Hong G., Deleersnjider W., Kozak C.A., van Marck E., Tylzanowski P.,
RA   Merregaert J.;
RT   "Molecular cloning of a highly conserved mouse and human integral
RT   membrane protein (Itm1) and genetic mapping to mouse chromosome 9.";
RL   Genomics 31:295-300(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8634329; DOI=10.1016/0167-4781(96)00025-5;
RA   Lissy N.A., Bellacosa A., Sonoda G., Miller P.D., Jhanwar S.C.,
RA   Testa J.R.;
RT   "Isolation, characterization, and mapping to human chromosome 11q24-25
RT   of a cDNA encoding a highly conserved putative transmembrane protein,
RT   TMC.";
RL   Biochim. Biophys. Acta 1306:137-141(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Duodenum, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12887896; DOI=10.1016/S1097-2765(03)00243-0;
RA   Kelleher D.J., Karaoglu D., Mandon E.C., Gilmore R.;
RT   "Oligosaccharyltransferase isoforms that contain different catalytic
RT   STT3 subunits have distinct enzymatic properties.";
RL   Mol. Cell 12:101-111(2003).
RN   [9]
RP   FUNCTION.
RX   PubMed=19167329; DOI=10.1016/j.cell.2008.11.047;
RA   Ruiz-Canada C., Kelleher D.J., Gilmore R.;
RT   "Cotranslational and posttranslational N-glycosylation of polypeptides
RT   by distinct mammalian OST isoforms.";
RL   Cell 136:272-283(2009).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-537; ASN-544 AND ASN-548.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=25135935; DOI=10.1083/jcb.201404083;
RA   Cherepanova N.A., Shrimal S., Gilmore R.;
RT   "Oxidoreductase activity is necessary for N-glycosylation of cysteine-
RT   proximal acceptor sites in glycoproteins.";
RL   J. Cell Biol. 206:525-539(2014).
RN   [14]
RP   IDENTIFICATION IN THE OLIGOSACCHARYLTRANSFERASE COMPLEX.
RX   PubMed=23606741; DOI=10.1242/jcs.115410;
RA   Dumax-Vorzet A., Roboti P., High S.;
RT   "OST4 is a subunit of the mammalian oligosaccharyltransferase required
RT   for efficient N-glycosylation.";
RL   J. Cell Sci. 126:2595-2606(2013).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   VARIANT CDG1W ALA-626, AND CHARACTERIZATION OF VARIANT CDG1W ALA-626.
RX   PubMed=23842455; DOI=10.1093/hmg/ddt312;
RA   Shrimal S., Ng B.G., Losfeld M.E., Gilmore R., Freeze H.H.;
RT   "Mutations in STT3A and STT3B cause two congenital disorders of
RT   glycosylation.";
RL   Hum. Mol. Genet. 22:4638-4645(2013).
CC   -!- FUNCTION: Catalytic subunit of the N-oligosaccharyl transferase
CC       (OST) complex which catalyzes the transfer of a high mannose
CC       oligosaccharide from a lipid-linked oligosaccharide donor to an
CC       asparagine residue within an Asn-X-Ser/Thr consensus motif in
CC       nascent polypeptide chains. N-glycosylation occurs
CC       cotranslationally and the complex associates with the Sec61
CC       complex at the channel-forming translocon complex that mediates
CC       protein translocation across the endoplasmic reticulum (ER). SST3A
CC       seems to be involved in complex substrate specificity. STT3A is
CC       present in the majority of OST complexes and mediates
CC       cotranslational N-glycosylation of most sites on target proteins,
CC       while STT3B-containing complexes are required for efficient post-
CC       translational glycosylation and mediate glycosylation of sites
CC       that have been skipped by STT3A. {ECO:0000250|UniProtKB:F1PJP5,
CC       ECO:0000269|PubMed:19167329, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY: Dolichyl diphosphooligosaccharide + [protein]-
CC       L-asparagine = dolichyl diphosphate + a glycoprotein with the
CC       oligosaccharide chain attached by N-beta-D-glycosyl linkage to a
CC       protein L-asparagine.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Component of the oligosaccharyltransferase (OST) complex.
CC       OST exists in two different complex forms which contain common
CC       core subunits RPN1, RPN2, OST48, OST4, DAD1 and TMEM258, either
CC       STT3A or STT3B as catalytic subunits, and form-specific accessory
CC       subunits. OST can form stable complexes with the Sec61 complex or
CC       with both the Sec61 and TRAP complexes.
CC       {ECO:0000250|UniProtKB:F1PJP5, ECO:0000269|PubMed:23606741,
CC       ECO:0000269|PubMed:25135935, ECO:0000305}.
CC   -!- INTERACTION:
CC       O43187:IRAK2; NbExp=2; IntAct=EBI-719212, EBI-447733;
CC       Q6PDS3:Sarm1 (xeno); NbExp=2; IntAct=EBI-719212, EBI-6117196;
CC       Q86WV6:TMEM173; NbExp=2; IntAct=EBI-719212, EBI-2800345;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:12887896}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P46978}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P46978}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P46977-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P46977-2; Sequence=VSP_055106;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in placenta, liver,
CC       muscle and pancreas, and at very low levels in brain, lung and
CC       kidney. Expressed in skin fibroblasts (at protein level).
CC       {ECO:0000269|PubMed:12887896}.
CC   -!- DISEASE: Congenital disorder of glycosylation 1W (CDG1W)
CC       [MIM:615596]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:23842455}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the STT3 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L38961; AAB05994.1; -; mRNA.
DR   EMBL; L47337; AAL77539.1; -; mRNA.
DR   EMBL; AK290040; BAF82729.1; -; mRNA.
DR   EMBL; AK290657; BAF83346.1; -; mRNA.
DR   EMBL; AK295892; BAG58686.1; -; mRNA.
DR   EMBL; BT007100; AAP35764.1; -; mRNA.
DR   EMBL; AP001132; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001494; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471065; EAW67647.1; -; Genomic_DNA.
DR   EMBL; BC020965; AAH20965.1; -; mRNA.
DR   EMBL; BC048348; AAH48348.2; -; mRNA.
DR   CCDS; CCDS60998.1; -. [P46977-2]
DR   CCDS; CCDS8458.1; -. [P46977-1]
DR   PIR; S70029; S70029.
DR   RefSeq; NP_001265432.1; NM_001278503.1. [P46977-1]
DR   RefSeq; NP_001265433.1; NM_001278504.1. [P46977-2]
DR   RefSeq; NP_689926.1; NM_152713.4. [P46977-1]
DR   RefSeq; XP_011541109.1; XM_011542807.2. [P46977-1]
DR   UniGene; Hs.504237; -.
DR   UniGene; Hs.659244; -.
DR   ProteinModelPortal; P46977; -.
DR   BioGrid; 109908; 23.
DR   IntAct; P46977; 39.
DR   MINT; MINT-1407187; -.
DR   STRING; 9606.ENSP00000376472; -.
DR   CAZy; GT66; Glycosyltransferase Family 66.
DR   TCDB; 9.B.142.3.4; the integral membrane glycosyltransferase family 39 (gt39) family.
DR   iPTMnet; P46977; -.
DR   PhosphoSitePlus; P46977; -.
DR   SwissPalm; P46977; -.
DR   DMDM; 182676409; -.
DR   EPD; P46977; -.
DR   MaxQB; P46977; -.
DR   PaxDb; P46977; -.
DR   PeptideAtlas; P46977; -.
DR   PRIDE; P46977; -.
DR   DNASU; 3703; -.
DR   Ensembl; ENST00000392708; ENSP00000376472; ENSG00000134910. [P46977-1]
DR   Ensembl; ENST00000529196; ENSP00000436962; ENSG00000134910. [P46977-1]
DR   Ensembl; ENST00000531491; ENSP00000432820; ENSG00000134910. [P46977-2]
DR   GeneID; 3703; -.
DR   KEGG; hsa:3703; -.
DR   UCSC; uc001qcd.4; human. [P46977-1]
DR   CTD; 3703; -.
DR   DisGeNET; 3703; -.
DR   GeneCards; STT3A; -.
DR   HGNC; HGNC:6172; STT3A.
DR   HPA; HPA030735; -.
DR   MalaCards; STT3A; -.
DR   MIM; 601134; gene.
DR   MIM; 615596; phenotype.
DR   neXtProt; NX_P46977; -.
DR   OpenTargets; ENSG00000134910; -.
DR   Orphanet; 370921; STT3A-CDG.
DR   PharmGKB; PA29969; -.
DR   eggNOG; KOG2292; Eukaryota.
DR   eggNOG; COG1287; LUCA.
DR   GeneTree; ENSGT00390000015238; -.
DR   HOGENOM; HOG000157471; -.
DR   HOVERGEN; HBG010606; -.
DR   InParanoid; P46977; -.
DR   KO; K07151; -.
DR   OMA; PIDVKMT; -.
DR   OrthoDB; EOG091G02DB; -.
DR   PhylomeDB; P46977; -.
DR   TreeFam; TF300822; -.
DR   Reactome; R-HSA-446203; Asparagine N-linked glycosylation.
DR   SignaLink; P46977; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; STT3A; human.
DR   GenomeRNAi; 3703; -.
DR   PRO; PR:P46977; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134910; -.
DR   CleanEx; HS_STT3A; -.
DR   ExpressionAtlas; P46977; baseline and differential.
DR   Genevisible; P46977; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008250; C:oligosaccharyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0004579; F:dolichyl-diphosphooligosaccharide-protein glycotransferase activity; IMP:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043686; P:co-translational protein modification; IMP:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; IBA:GO_Central.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; IMP:UniProtKB.
DR   InterPro; IPR003674; Oligo_trans_STT3.
DR   Pfam; PF02516; STT3; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Glycoprotein; Glycosyltransferase; Magnesium;
KW   Membrane; Metal-binding; Reference proteome; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    705       Dolichyl-diphosphooligosaccharide--
FT                                protein glycosyltransferase subunit
FT                                STT3A.
FT                                /FTId=PRO_0000072290.
FT   TOPO_DOM      1     17       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     18     38       Helical. {ECO:0000255}.
FT   TOPO_DOM     39    114       Lumenal. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical. {ECO:0000255}.
FT   TOPO_DOM    136    169       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    170    190       Helical. {ECO:0000255}.
FT   TOPO_DOM    191    208       Lumenal. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    235       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    236    259       Helical. {ECO:0000255}.
FT   TOPO_DOM    260    265       Lumenal. {ECO:0000255}.
FT   TRANSMEM    266    286       Helical. {ECO:0000255}.
FT   TOPO_DOM    287    300       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    301    321       Helical. {ECO:0000255}.
FT   TOPO_DOM    322    359       Lumenal. {ECO:0000255}.
FT   TRANSMEM    360    380       Helical. {ECO:0000255}.
FT   TOPO_DOM    381    383       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    384    404       Helical. {ECO:0000255}.
FT   TOPO_DOM    405    405       Lumenal. {ECO:0000255}.
FT   TRANSMEM    406    426       Helical. {ECO:0000255}.
FT   TOPO_DOM    427    453       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    454    474       Helical. {ECO:0000255}.
FT   TOPO_DOM    475    705       Lumenal. {ECO:0000255}.
FT   CARBOHYD    537    537       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    544    544       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    548    548       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   VAR_SEQ       1     92       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055106.
FT   VARIANT     626    626       V -> A (in CDG1W; affects activity
FT                                resulting in hypoglycosylation of STT3A-
FT                                specific substrates; dbSNP:rs587777216).
FT                                {ECO:0000269|PubMed:23842455}.
FT                                /FTId=VAR_070944.
FT   CONFLICT     61     61       A -> S (in Ref. 2; AAL77539).
FT                                {ECO:0000305}.
FT   CONFLICT    117    117       V -> M (in Ref. 3; BAG58686).
FT                                {ECO:0000305}.
FT   CONFLICT    128    128       T -> S (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    133    133       H -> L (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    252    252       M -> R (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    270    270       A -> G (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    415    415       C -> S (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    454    454       N -> I (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
FT   CONFLICT    494    494       G -> D (in Ref. 2; AAL77539).
FT                                {ECO:0000305}.
FT   CONFLICT    681    681       A -> G (in Ref. 1; AAB05994).
FT                                {ECO:0000305}.
SQ   SEQUENCE   705 AA;  80530 MW;  71426CA5598B51C4 CRC64;
     MTKFGFLRLS YEKQDTLLKL LILSMAAVLS FSTRLFAVLR FESVIHEFDP YFNYRTTRFL
     AEEGFYKFHN WFDDRAWYPL GRIIGGTIYP GLMITSAAIY HVLHFFHITI DIRNVCVFLA
     PLFSSFTTIV TYHLTKELKD AGAGLLAAAM IAVVPGYISR SVAGSYDNEG IAIFCMLLTY
     YMWIKAVKTG SICWAAKCAL AYFYMVSSWG GYVFLINLIP LHVLVLMLTG RFSHRIYVAY
     CTVYCLGTIL SMQISFVGFQ PVLSSEHMAA FGVFGLCQIH AFVDYLRSKL NPQQFEVLFR
     SVISLVGFVL LTVGALLMLT GKISPWTGRF YSLLDPSYAK NNIPIIASVS EHQPTTWSSY
     YFDLQLLVFM FPVGLYYCFS NLSDARIFII MYGVTSMYFS AVMVRLMLVL APVMCILSGI
     GVSQVLSTYM KNLDISRPDK KSKKQQDSTY PIKNEVASGM ILVMAFFLIT YTFHSTWVTS
     EAYSSPSIVL SARGGDGSRI IFDDFREAYY WLRHNTPEDA KVMSWWDYGY QITAMANRTI
     LVDNNTWNNT HISRVGQAMA STEEKAYEIM RELDVSYVLV IFGGLTGYSS DDINKFLWMV
     RIGGSTDTGK HIKENDYYTP TGEFRVDREG SPVLLNCLMY KMCYYRFGQV YTEAKRPPGF
     DRVRNAEIGN KDFELDVLEE AYTTEHWLVR IYKVKDLDNR GLSRT
//
